We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
-18.56%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.67B
AUM Growth
-$412M
Cap. Flow
+$65.2M
Cap. Flow %
3.89%
Top 10 Hldgs %
54.47%
Holding
343
New
97
Increased
69
Reduced
59
Closed
44

Sector Composition

Rank Sector Weight
1 Healthcare 39.37%
2 Financials 7.66%
3 Consumer Discretionary 5.31%
4 Communication Services 3.82%
5 Industrials 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
176
Mondelez International
MDLZ
$79.5B
$656K 0.04%
16,400
-5,000
-23% -$213K
LXRX icon
177
Lexicon Pharmaceuticals
LXRX
$1.03B
$639K 0.04%
+100,621
New +$815K
MDCO
178
DELISTED
Medicines Co
MDCO
$636K 0.04%
+34,000
New +$791K
AMGN icon
179
Amgen
AMGN
$208B
$634K 0.04%
3,330
AU icon
180
AngloGold Ashanti
AU
$40.1B
$626K 0.04%
50,000
C icon
181
Citigroup
C
$222B
$621K 0.04%
12,000
-535
-4% -$33.9K
INTU icon
182
Intuit
INTU
$86.5B
$620K 0.04%
3,145
BLRX
183
BioLineRX
BLRX
$12.3M
$611K 0.04%
2,262
PTGX icon
184
Protagonist Therapeutics
PTGX
$8.79B
$609K 0.04%
+96,513
New +$766K
EL icon
185
Estee Lauder
EL
$30.4B
$605K 0.04%
4,710
-7,390
-61% -$1M
AG icon
186
First Majestic Silver
AG
$7.41B
$596K 0.04%
100,000
MS icon
187
Morgan Stanley
MS
$331B
$596K 0.04%
+15,041
New +$656K
BIIB icon
188
Biogen
BIIB
$30B
$589K 0.04%
2,000
CHRS icon
189
Coherus Oncology
CHRS
$217M
$576K 0.03%
+65,500
New +$758K
STML
190
DELISTED
Stemline Therapeutics, Inc.
STML
$572K 0.03%
+58,000
New +$752K
INFY icon
191
Infosys
INFY
$48.7B
$566K 0.03%
+59,930
New +$572K
LVS icon
192
Las Vegas Sands
LVS
$31.7B
$557K 0.03%
10,900
-9,100
-46% -$493K
ARWR icon
193
Arrowhead Research
ARWR
$11.9B
$551K 0.03%
+46,000
New +$629K
B
194
Barrick Mining
B
$61.5B
$548K 0.03%
40,000
-45,000
-53% -$582K
BOLD
195
DELISTED
Audentes Therapeutics, Inc
BOLD
$546K 0.03%
+26,000
New +$671K
IAG icon
196
IAMGOLD
IAG
$8.2B
$545K 0.03%
150,000
+50,000
+50% +$175K
TBIO
197
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$545K 0.03%
+74,000
New +$542K
DECK icon
198
Deckers Outdoor
DECK
$13.2B
$544K 0.03%
25,020
GM icon
199
General Motors
GM
$80.4B
$543K 0.03%
16,000
-2,000
-11% -$69K
DHR icon
200
Danaher
DHR
$137B
$538K 0.03%
5,978
-13,988
-70% -$1.27M

Similar funds

Fosun International's Q4 2018 Portfolio in Review

As of Q4 2018, Fosun International held 343 positions worth $1.67B, down 20% from $2.09B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Fosun International deployed $65.2M of net new capital in Q4 2018, opening 97 new positions and adding to 69 existing holdings. Its largest new stake was Albireo Pharma Inc: 197,005 shares worth $4.49M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Brookdale Senior Living, an estimated $57.6M trimmed.

  • Fosun International's largest Q4 2018 buy was Albireo Pharma Inc: 197,005 shares worth $4.49M.
  • Fosun International added most to Seadrill Limited Common Stock in Q4 2018, an estimated $25.6M increase.
  • Fosun International's biggest Q4 2018 reduction was Brookdale Senior Living, cutting an estimated $57.6M.
  • Fosun International fully exited Bilibili in Q4 2018, selling an estimated $13M.
  • Fosun International's ten largest holdings make up 54% of its $1.67B portfolio in Q4 2018.
  • Fosun International opened 97 new positions and closed 44 in Q4 2018.
  • Fosun International's portfolio value fell 20% quarter-over-quarter to $1.67B.

Based on Fosun International's 13F filing for Q4 2018, filed 31 Jan 2019.